INTERNATIONAL PATENT: BOEHRINGER INGELHEIM INTERNATIONAL GMBH FILES APPLICATION FOR "GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS FOR USE IN THE TREATMENT OF SUBSTANCE USE DISORDER IN PATIENTS WITH HIGH IMPULSIVITY"

GENEVA, April 5 -- BOEHRINGER INGELHEIM INTERNATIONAL GMBH (Binger Strasse 17355216 INGELHEIM AM RHEIN) filed a patent application (PCT/EP2025/076974) for "GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS FOR USE IN THE TREATMENT OF SUBSTANCE USE DISORDER IN PATIENTS WITH HIGH IMPULSIVITY" on Sep 22, 2025. With publication no. WO/2026/068388, the details related to the patent application was published on Apr 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JUST, Stefan (Boehringer Ingelheim International GmbHGlobal PatentsBinger Strasse 17355216 INGELHEIM AM RHEIN), CRUCES SOLIS, Hugo (Boehri...